Lv1
94 积分 2024-03-19 加入
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE)
2天前
已完结
Baseline Blood Eosinophil Count for Identifying Superior Responders to Biologics in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis
10天前
已完结
Biomarkers for early diagnosis of rheumatoid arthritis
20天前
已完结
Management and Research Progress of Severe Asthma in China
1个月前
已完结
Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink
1个月前
已完结
Current issues in rheumatoid arthritis-associated interstitial lung disease
1个月前
已关闭
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
1个月前
已完结
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
1个月前
已完结
Managing Cough in Idiopathic Pulmonary Fibrosis
1个月前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
1个月前
已完结
皖公网安备34019202002308
